Effects of ezetimibe on postprandial hyperlipidaemia and hyperglycemia in Japanese hyperlipidemic patients; Double-blinded crossover randomized clinical trial
Not Applicable
- Conditions
- hyperlipidemic subjects
- Registration Number
- JPRN-UMIN000002954
- Lead Sponsor
- Graduate School of Medicine, Yokohama City University Department of Endocrinology & Metabolism
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1.Subjects who are hypersensitive to this medicine and/or contaminants of this medicine. 2.Subjects who have a severe hepatic or renal dysfunction. 3.Subjects who have already been treated with anti-dyslipidemic and/or anti-diabetic agent within 3 months of the study entry
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.The change in serum lipid levels(TG,Apo48,RLP-C, oxidized cholesterol)
- Secondary Outcome Measures
Name Time Method 1.The alteration in glucose metabolism 2.The change in serum hs-CRP, TNF- 3.The change in serum total adiponectin concentration